At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
VNRX VolitionRX
Not Yet Opened 03-19 16:00:00 EDT
0.1900
-0.0100
-5.00%
盘后0.1900
+0.0000-0.01%
19:59 EDT
High0.2129Low0.1800Vol15.96M
Open0.2002D1 Closing0.2000Amplitude16.45%
Mkt Cap25.76MTradable Cap17.55MTotal Shares135.57M
T/O3.10MT/O Rate17.28%Tradable Shares92.35M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

VolitionRX Is Maintained at Buy by D. Boral Capital
Dow Jones  ·  03-19 01:53
VolitionRX Is Maintained at Buy by D. Boral Capital
BRIEF-Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Reuters  ·  03-18 20:20
BRIEF-Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
VolitionRx reports clinical validation results showing 49/49 cancers detected with no false positives
Reuters  ·  03-18 20:17
VolitionRx reports clinical validation results showing 49/49 cancers detected with no false positives
Volition Reports Breakthrough in Liquid Biopsy: Achievement of Over 99% Purity in Isolating Cancer DNA
THOMSON REUTERS  ·  03-18 20:17
Volition Reports Breakthrough in Liquid Biopsy: Achievement of Over 99% Purity in Isolating Cancer DNA
VolitionRx and Fujifilm Vet Systems Validate Automated Nu.Q Vet Cancer Test in Japan
Reuters  ·  03-06
VolitionRx and Fujifilm Vet Systems Validate Automated Nu.Q Vet Cancer Test in Japan
Volition Announces First Ever Automated Nu.q® Vet Cancer Test With Fujifilm Vet Systems
THOMSON REUTERS  ·  03-06
Volition Announces First Ever Automated Nu.q® Vet Cancer Test With Fujifilm Vet Systems
VolitionRx reports progress on Capture-Seq, Nu.Q lung cancer reimbursement, and Nu.Q NETs sepsis program in France
Reuters  ·  02-25
VolitionRx reports progress on Capture-Seq, Nu.Q lung cancer reimbursement, and Nu.Q NETs sepsis program in France
VolitionRX Issues Unregistered Shares to Lind Global Asset Management XII LLC
Reuters  ·  02-21
VolitionRX Issues Unregistered Shares to Lind Global Asset Management XII LLC
VolitionRX Appoints MBL as Distributor for Nu.Q Discover Assays in Japan
Reuters  ·  02-10
VolitionRX Appoints MBL as Distributor for Nu.Q Discover Assays in Japan
VolitionRx Faces NYSE American Non-Compliance Notice Over Equity Requirements
Reuters  ·  02-10
VolitionRx Faces NYSE American Non-Compliance Notice Over Equity Requirements
VolitionRX Receives Notice of Non-Compliance With Nyse American Continued Listing Standards
THOMSON REUTERS  ·  02-10
VolitionRX Receives Notice of Non-Compliance With Nyse American Continued Listing Standards
VolitionRx Unveils Clinical Study Showing Nu.Q NETs Blood Test Guides Hidradenitis Suppurativa Treatment
Reuters  ·  02-04
VolitionRx Unveils Clinical Study Showing Nu.Q NETs Blood Test Guides Hidradenitis Suppurativa Treatment
VolitionRX Limited Announces the Preparation of Reimbursement Submission for Its Nu.q® Cancer Assays
THOMSON REUTERS  ·  01-30
VolitionRX Limited Announces the Preparation of Reimbursement Submission for Its Nu.q® Cancer Assays
VolitionRX Ltd: Once Reimbursement Achieved Anticipate Introduction of Nu.q Into Routine Clinical Use in France by Q4, 2026
THOMSON REUTERS  ·  01-30
VolitionRX Ltd: Once Reimbursement Achieved Anticipate Introduction of Nu.q Into Routine Clinical Use in France by Q4, 2026
VolitionRx Unveils Study Supporting Nu.Q NETs Blood Test for Hidradenitis Suppurativa Management
Reuters  ·  01-28
VolitionRx Unveils Study Supporting Nu.Q NETs Blood Test for Hidradenitis Suppurativa Management
Volition Announces Data to Support Use of Nu.q® Nets in New Indication
THOMSON REUTERS  ·  01-27
Volition Announces Data to Support Use of Nu.q® Nets in New Indication
VolitionRX Ltd. Announces Date for Upcoming Special Meeting of Stockholders
Reuters  ·  01-27
VolitionRX Ltd. Announces Date for Upcoming Special Meeting of Stockholders
VolitionRX Is Maintained at Buy by D. Boral Capital
Dow Jones  ·  01-21
VolitionRX Is Maintained at Buy by D. Boral Capital
VolitionRX Expands Nu.Q Vet Cancer Test Access With New Laboratory Providers
Reuters  ·  01-20
VolitionRX Expands Nu.Q Vet Cancer Test Access With New Laboratory Providers
VolitionRX Ltd. Showcases Nu.Q Vet Cancer Test at VMX Veterinary Conference
Reuters  ·  01-16
VolitionRX Ltd. Showcases Nu.Q Vet Cancer Test at VMX Veterinary Conference

Introduction

Company Name.
VolitionRX
Affiliated Markets:
AMEX
Listing Date:
--
Main Business:
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 worldwide. It offers Nu.Q Vet cancer screening blood test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer that detect cancer; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company is based in Henderson, Nevada.
Issue price:
--